PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 20,000 employees worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
About PPD® Biotech
PPD Biotech is a Phase I-IV CRO service provider devoted to biotech and small to mid-size pharma companies. Operating as a company within a company, we offer dedicated drug development resources who understand the unique needs of biotech companies.
We combine the global power and capabilities of PPD with the personal attention, flexibility and extensive knowledge of biotech operations you could previously only find at niche CROs. We stand ready to partner with you to drive your innovative therapies forward.
PPD’s focus on patient centricity is manifested in our Accelerated Enrollment Solutions (AES) business unit, offering sponsors and contract research organizations (CROs) best-in-class patient access and clinical research site solutions. AES is the new standard in clinical trial productivity, delivering more patients from fewer sites in less time.